** Shares of medical software firm Omnicell OMCL.O fall as much as 16.7% to a near 10-month low of $25.39
** OMCL cuts its 2025 adj profit forecast to a range of $1 and $1.65 per share, compared with previously projected range of $1.65 to $1.85e
** Company, however, maintains its 2025 revenue forecast in the range of $1.11 billion to $1.16 billion
** Company posts Q1 revenue of $270 million vs analysts' estimates of $260 million - data compiled by LSEG
** Up to last close, stock had fallen 44.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。